Alpha Mannosidosis - Global Forecast 2024-2030

by Treatment Type (Bone Marrow Transplant, Enzyme Replacement Therapy), Indication (Type I, Type II, Type III), End-User

Published	Pages	Publisher	Report code
Jan 2024	192	360 iResearch	ASDR-644359

Published: Jan 2024 - Pages : 192 - Publisher : 360 iResearch - Report code : ASDR-644359

1. Chiesi Farmaceutici S.p.A.
2. Cigna Corporation
3. CVS Caremark
4. Kamada Ltd.
5. Orient Europharma (M) Sdn Bhd
6. Talaris Therapeutics Inc.